End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
17,350 KRW | -1.87% | +1.23% | +6.12% |
Sep. 11 | Tiantan Biological Unit Registers Blood Disorder Treatment; Shares Jump 4% | MT |
Aug. 02 | Green Cross's Net Income Plunges in Q2 | MT |
Sales 2022 | 2,080B 1.54B | Sales 2023 | 2,058B 1.53B | Capitalization | 746B 553M |
---|---|---|---|---|---|
Net income 2022 | 32.82B 24.35M | Net income 2023 | -54.14B -40.17M | EV / Sales 2022 | 0.79 x |
Net Debt 2022 | 858B 637M | Net Debt 2023 | 1,084B 804M | EV / Sales 2023 | 0.89 x |
P/E ratio 2022 |
23.8
x | P/E ratio 2023 |
-13.5
x | Employees | 165 |
Yield 2022 |
1.76% | Yield 2023 |
-
| Free-Float | 43.91% |
1 day | -1.87% | ||
1 week | +1.23% | ||
Current month | +5.15% | ||
1 month | +1.76% | ||
3 months | +9.46% | ||
6 months | +24.46% | ||
Current year | +6.12% |
Managers | Title | Age | Since |
---|---|---|---|
Yong-Jun Huh
CEO | Chief Executive Officer | 49 | 10-02-28 |
Il-Sup Huh
CEO | Chief Executive Officer | 69 | 91-05-31 |
Yeon-Geun Kim
DFI | Director of Finance/CFO | 51 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Il-Sup Huh
CEO | Chief Executive Officer | 69 | 91-05-31 |
Yong-Tae Park
BRD | Director/Board Member | 74 | 09-02-28 |
Yong-Jun Huh
CEO | Chief Executive Officer | 49 | 10-02-28 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 7 M€ | +4.29% | - | |
0.00% | 4 M€ | -4.41% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-27 | 17,350 | -1.87% | 68 514 |
24-03-27 | 17,680 | -0.67% | 74,484 |
24-03-26 | 17,800 | +0.06% | 77,814 |
24-03-25 | 17,790 | +0.51% | 69,944 |
24-03-22 | 17,700 | +1.32% | 108,155 |
End-of-day quote Korea S.E., March 27, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
+6.12% | 596M | |
+33.46% | 701B | |
+26.24% | 571B | |
+0.93% | 381B | |
+21.03% | 334B | |
+17.51% | 319B | |
+0.74% | 210B | |
+2.95% | 210B | |
-6.05% | 201B | |
-3.61% | 157B |